HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

3-Hydroxy Imiquimod

HCID 178833410
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1807606-78-5
Standard SMILES
CC(CO)Cn1cnc2c(N)nc3ccccc3c21
InChIKey
HRATYRRGCLIWCL-UHFFFAOYSA-N
Molecular formula
C14H16N4O
Average molar mass
256.3 g/mol

Names & identifiers

Preferred name
3-Hydroxy Imiquimod
IUPAC
3-(4-aminoimidazo[4,5-c]quinolin-1-yl)-2-methylpropan-1-ol
English name
Imiquimod Impurity 2
Molecular formula
C14H16N4O
Molecular weight
256.30304

Names & synonyms

3-Hydroxy Imiquimod1807606-78-53-(4-aminoimidazo[4,5-c]quinolin-1-yl)-2-methylpropan-1-ol3-(4-amino-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-1-ol3-{4-amino-1H-imidazo[4,5-c]quinolin-1-yl}-2-methylpropan-1-ol4-Amino-beta-methyl-1H-imidazo[4,5-c]quinoline-1-propanol3-Hydroxy Imiquimod;Imiquimod Impurity 14SCHEMBL6106966SCHEMBL31665908HRATYRRGCLIWCL-UHFFFAOYSA-NImiquimod Impurity 2 (S-27700)
Show more names
Imiquimod Impurity 23-Hydroxy Imiquimod (S-27700)1H-Imidazo[4,5-c]quinoline-1-propanol, 4-amino-β-methyl-
1H-Imidazo[4,5-c]quinoline-1-propanol, 4-amino-beta-methyl-

Database identifiers

CAS
1807606-78-5

Properties

Computed structural propertiesFilling in

XLogP
1.4
Topological polar surface area
77 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
3
Heavy atoms
19
Formal charge
0
Complexity
314

Physicochemical properties

Boiling point
532.4 · 532.4±60.0 °C(Predicted)
Density
1.37 · 1.37±0.1 g/cm3(Predicted)
solubility
DMSO (Slightly), Methanol (Slightly)
form
Solid
pka
14.83 · 14.83±0.10(Predicted)
color
White to Off-White

Chemistry & industry

Applications

Uses4-Amino-b-methyl-1H-imidazo[4,5-c]quinoline-1-propanol, is an aryl ether substituted imidazoquinolines, which can be used in the design of immunomodulating agents for use as vaccine adjuvants and anticancer treatments.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes